Arcutis Biotherapeutics announced the launch of The Cream That Can, the first commercial direct-to-consumer ad for ZORYVE cream 0.3% for the treatment of plaque psoriasis, including intertriginous psoriasis in adults and adolescents. The Cream That Can campaign invites individuals with psoriasis to reimagine a steroid-free cream for their psoriasis.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ARQT:
- Arcutis Launches First Television Ad for ZORYVE® (Roflumilast) Cream 0.3%
- Arcutis Appoints Interim Chief Financial Officer (CFO)
- Arcutis CFO Scott Burrows to leave, John Smither named interim CFO
- Cantor biotech/biopharma analysts to hold analyst/industry conference call
- Arcutis, Huadong announce strategic collaboration, agreement for Roflumilast